i-SENS Inc (099190)
KOSDAQ · Korea · prices in KRW · close of 27 Oct 2026
Key indicators
| Last close | KRW 15,730.00 |
|---|---|
| 52-week range | 14,000.00 – 27,600.00 |
| Return, 1 month / 3 months | −0.8% / −10.1% |
| Return, 1 year / 3 years | −11.4% / −29.4% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 53.5% |
| Worst drawdown (1 year) | -45.6% |
| Average daily value traded | 720.73M KRW |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
i-SENS Inc is a Korean medical device company that develops and manufactures blood glucose monitoring systems, including glucose meters, test strips and continuous glucose monitoring devices. Its products serve people with diabetes who check their blood sugar at home, as well as clinics and healthcare professionals who need point-of-care diagnostic testing. The company is based in Korea and sells its monitoring products under its own brand to customers in domestic and international markets.
i-SENS Inc trades under the code 099190 on the KOSDAQ in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
i-SENS Inc (099190) trades on the KOSDAQ in Korea. It last closed at KRW 15,730.00 on 27 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 607 of 1,833 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.4% and over the last three months it fell 10.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -12.3% | ||
| From 52-week high | -41.7% | ||
| Momentum | 50 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.1% | ||
| 6-month return | -27.8% | ||
| 12-month return, skipping the last month | -10.6% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 53.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.6% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 720.73M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.7% |
|---|---|
| 1 month | −0.8% |
| 3 months | −10.1% |
| 6 months | −27.8% |
| 1 year | −11.4% |
| 3 years | −29.4% |
| 5 years | −3.2% |
Signals
| 50-day / 200-day average | 16,803.00 / 17,936.75 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 654.04 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Dec 2025 | KRW 100.0000 |
| 27 Dec 2024 | KRW 100.0000 |
| 27 Dec 2023 | KRW 100.0000 |
| 28 Dec 2022 | KRW 350.0000 |
| 29 Dec 2021 | KRW 300.0000 |
| 29 Dec 2020 | KRW 250.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.